Droxidopa approved for neurogenic orthostatic hypotension

被引：0
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2014年 / 71卷 / 07期
关键词：
D O I：
10.2146/news140024
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：520 / 520
页数：1
相关论文
共 50 条
  • [41] INTEGRATED EFFICACY AND SAFETY ANALYSES OF DROXIDOPA FOR SYMPTOMATIC NEUROGENIC ORTHOSTATIC HYPOTENSION
    Hauser, R. A.
    Hewitt, L. A.
    Lee, D.
    Ziemann, A.
    Kaufmann, H.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 156 - 156
  • [42] Effect of Age on the Efficacy and Safety of Droxidopa for Symptomatic Neurogenic Orthostatic Hypotension
    Peng, Guangbin
    Rowse, Gerald
    Couchenour, Rachel
    Beier, Manju
    [J]. NEUROLOGY, 2016, 86
  • [43] Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)
    Francois, C.
    McLeod, K.
    Duhig, A.
    Ogbonnaya, A.
    Quillen, A.
    Cannon, J.
    Padilla, B.
    Shibao, C. A.
    Biaggioni, I.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S147 - S147
  • [44] Subgroup efficacy analysis: Orthostatic hypotension questionnaire composite score in patients with neurogenic orthostatic hypotension treated with droxidopa
    Wenning, G.
    Low, P.
    Szakacs, C.
    Kaufmann, H.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S429 - S429
  • [45] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension Reply
    Brignole, Michele
    Fanciulli, Alessandra
    van Dijk, Gert
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (01) : 71 - 71
  • [46] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Francois, Clement
    Rowse, Gerald J.
    Hewitt, L. Arthur
    Vo, Pamela
    Hauser, Robert A.
    [J]. BMC NEUROLOGY, 2016, 16
  • [47] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
    Kremens, Daniel
    Lew, Mark
    Claassen, Daniel
    Goodman, Brent P.
    [J]. CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S29 - S31
  • [48] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Clément François
    Gerald J. Rowse
    L. Arthur Hewitt
    Pamela Vo
    Robert A. Hauser
    [J]. BMC Neurology, 16
  • [49] Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hauser, Robert A.
    Biaggioni, Italo
    Hewitt, L. Arthur
    Vernino, Steven
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (06): : 627 - 634
  • [50] Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension
    Hauser, Robert A.
    Heritier, Stephane
    Rowse, Gerald J.
    Hewitt, L. Arthur
    Isaacson, Stuart H.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2016, 39 (05) : 220 - 226
12345